{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:19:53Z","timestamp":1790878793245,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Infectious agents have been identified in the etiology of certain non-Hodgkin lymphoma (NHL) subtypes and solid tumors. The impact of this shared etiology on risk for second cancers in NHL survivors has not been comprehensively studied. We used US population\u2013based cancer registry data to quantify risk of solid malignancies associated with infectious etiology among 127\u2009044 adult 1-year survivors of the 4 most common NHL subtypes diagnosed during 2000 to 2014 (mean follow-up, 4.5-5.2 years). Compared with the general population, elevated risks for liver, stomach, and anal cancers were observed among diffuse large B-cell lymphoma (DLBCL) survivors (standardized incidence ratio [SIR], 1.85; 95% confidence interval [CI], 1.46-2.31; SIR, 1.51; 95% CI, 1.16-1.94; SIR, 3.71; 95% CI, 2.52-5.27, respectively) and marginal zone lymphoma (MZL; SIR, 1.98; 95% CI, 1.34-2.83; SIR, 2.78; 95% CI, 2.02-3.74; SIR, 2.36; 95% CI, 1.02-4.64, respectively) but not follicular lymphoma or chronic lymphocytic leukemia\/small lymphocytic lymphoma. Anal cancer risk was particularly elevated among DLBCL survivors with HIV (SIR, 68.34; 95% CI, 37.36-114.66) vs those without (SIR, 2.09; 95% CI, 1.22-3.34). The observed patterns are consistent with shared associations between these cancers and hepatitis C virus, Helicobacter pylori, and HIV, respectively. In contrast, risks for cervical and oropharyngeal\/tonsil cancers were not elevated among survivors of any NHL subtype, possibly because of the lack of NHL association with human papillomavirus or population-wide screening practices (for cervical cancer). In summary, patterns of elevated second cancer risk differed by NHL subtype. Our results suggest shared infectious etiology has implications for subsequent cancer risks among DLBCL and MZL survivors, which may help inform surveillance for these survivors.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019030924","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T16:49:14Z","timestamp":1561999754000},"page":"1961-1969","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes"],"prefix":"10.1182","volume":"3","author":[{"given":"Megan M.","family":"Herr","sequence":"first","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Schonfeld","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3985-2935","authenticated-orcid":false,"given":"Gra\u00e7a M.","family":"Dores","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD;"},{"name":"Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[{"name":"Infections and Immunoepidemiology Branch and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0274-6773","authenticated-orcid":false,"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[{"name":"Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle E.","family":"Curtis","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Morton","sequence":"additional","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"3","key":"2020021108161507800_B1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","article-title":"Infectious agents as causes of non-Hodgkin lymphoma","volume":"16","author":"Engels","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"2020021108161507800_B2","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2020021108161507800_B3","first-page":"1","article-title":"Biological agents. Volume 100 B. A review of human carcinogens","volume":"100","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"33","key":"2020021108161507800_B4","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1200\/JCO.2010.29.1112","article-title":"Second malignancy risks after non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype","volume":"28","author":"Morton","year":"2010","journal-title":"J Clin Oncol"},{"key":"2020021108161507800_B5","volume-title":"Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"issue":"6","key":"2020021108161507800_B6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"2020021108161507800_B7","doi-asserted-by":"crossref","first-page":"e181999","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus\u2013associated cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2020021108161507800_B8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"issue":"5192","key":"2020021108161507800_B9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"2020021108161507800_B10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"2020021108161507800_B11","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.22912","article-title":"Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003","volume":"121","author":"Turesson","year":"2007","journal-title":"Int J Cancer"},{"issue":"11","key":"2020021108161507800_B12","first-page":"1860","article-title":"Report of the committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"2020021108161507800_B13","volume-title":"Epicure Risk Regression and Person-Year Computation Software: Command Summary and User Guide","author":"Preston","year":"2015"},{"issue":"11","key":"2020021108161507800_B14","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/aje\/kwg278","article-title":"A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers","volume":"158","author":"Yasui","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2020021108161507800_B15","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/bcj.2014.40","article-title":"Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity","volume":"4","author":"Kuo","year":"2014","journal-title":"Blood Cancer J"},{"issue":"16","key":"2020021108161507800_B16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":"Helicobacter pylori infection and the risk of gastric carcinoma","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"issue":"18","key":"2020021108161507800_B17","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","article-title":"Helicobacter pylori infection and gastric lymphoma","volume":"330","author":"Parsonnet","year":"1994","journal-title":"N Engl J Med"},{"issue":"16","key":"2020021108161507800_B18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":"Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii","volume":"325","author":"Nomura","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"2020021108161507800_B19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1077::AID-CNCR4>3.0.CO;2-D","article-title":"Iwanaga Si, Yao T, Tsuneyoshi M, Fujishima M. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma","volume":"79","author":"Nakamura","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"2020021108161507800_B20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"issue":"4","key":"2020021108161507800_B21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1440-1746.2009.06204.x","article-title":"Long-term treatment of localized gastric marginal zone B-cell mucosa associated lymphoid tissue lymphoma including incidence of metachronous gastric cancer","volume":"25","author":"Ono","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2020021108161507800_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1283033","article-title":"Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma","volume":"58","author":"Amiot","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"2020021108161507800_B23","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","article-title":"Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study","volume":"44","author":"Capelle","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"2020021108161507800_B24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2010.07.014","article-title":"Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma","volume":"305","author":"Kim","year":"2011","journal-title":"Cancer Lett"},{"issue":"9","key":"2020021108161507800_B25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","article-title":"Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study","volume":"11","author":"Engels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"43","key":"2020021108161507800_B26","doi-asserted-by":"crossref","first-page":"16197","DOI":"10.3748\/wjg.v20.i43.16197","article-title":"Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?","volume":"20","author":"Khoury","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2020021108161507800_B27","first-page":"34","article-title":"HIV- positive anal cancer: an update for the clinician","volume":"1","author":"Dandapani","year":"2010","journal-title":"J Gastrointest Oncol"},{"issue":"20","key":"2020021108161507800_B28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","article-title":"Impact of the HIV epidemic on the incidence rates of anal cancer in the United States","volume":"104","author":"Shiels","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2020021108161507800_B29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15","key":"2020021108161507800_B30","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS"},{"issue":"48","key":"2020021108161507800_B31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jncimonographs\/lgu010","article-title":"Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Cerhan","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"48","key":"2020021108161507800_B32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jncimonographs\/lgu011","article-title":"Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Bracci","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"2020021108161507800_B33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjh.14530","article-title":"Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012)","volume":"177","author":"Baras","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"2020021108161507800_B34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6602654","article-title":"Second primary cancers among 109 000 cases of non-Hodgkin\u2019s lymphoma","volume":"93","author":"Brennan","year":"2005","journal-title":"Br J Cancer"},{"issue":"11","key":"2020021108161507800_B35","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00432-015-1979-1","article-title":"Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study","volume":"141","author":"Chien","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2020021108161507800_B36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjh.14638","article-title":"Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era","volume":"178","author":"Tao","year":"2017","journal-title":"Br J Haematol"},{"issue":"8871","key":"2020021108161507800_B37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"2020021108161507800_B38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/157488410791110751","article-title":"Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas","volume":"5","author":"Arcaini","year":"2010","journal-title":"Curr Clin Pharmacol"},{"issue":"2","key":"2020021108161507800_B39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"2020021108161507800_B40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"2020021108161507800_B41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/1042819021000040341","article-title":"HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96\/90 registration study","volume":"44","author":"D\u2019Addario","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"2020021108161507800_B42","unstructured":"National Comprehensive Cancer Network. NCCN guidelines. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed 6 April 2019."},{"key":"2020021108161507800_B43","article-title":"Prevalence of hepatitis B virus, hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices [published online ahead of print 17 January 2019; published correction appears in JAMA Oncol. 7 March 2019]","author":"Ramsey","journal-title":"JAMA Oncol"},{"issue":"2","key":"2020021108161507800_B44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2020021108161507800_B45","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"2020021108161507800_B46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/13\/1961\/1631977\/advances030924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/13\/1961\/1631977\/advances030924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T08:21:06Z","timestamp":1581409266000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/13\/1961\/246606\/Risk-for-malignancies-of-infectious-etiology-among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019030924","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}